Mercer Global Advisors Inc Talis Biomedical Corp Transaction History

Mercer Global Advisors Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.48 - $0.64 $672 - $896	-1,400 Reduced 1.72%	79,880 $39,000
Q4 2022 Feb 08, 2023	BUY	$0.45 - $11.67 $630 - $16,338	1,400 Added 1.75%	81,280 $36,000
Q2 2022 Aug 10, 2022	BUY	$0.81 - $1.44 $55,485 - $98,640	68,500 Added 601.93%	79,880 $65,000
Q1 2022 May 10, 2022	BUY	$1.3 - $4.19 $448 - $1,445	345 Added 3.13%	11,380 $16,000
Q4 2021 Feb 04, 2022	SELL	$3.81 - $6.17 $34,290 - $55,530	-9,000 Reduced 44.92%	11,035 $44,000
Q1 2021 May 11, 2021	BUY	$11.2 - $27.8 $224,392 - $556,973	20,035 New	20,035 $257,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.